نتایج جستجو برای: k562 cells

تعداد نتایج: 1384167  

2015
Kejun Chen Shuqing Lü Hui Cheng Gusheng Tang Min Liu Hong Zhou Jianmin Wang

Neuroguidin (NGDN) is a eukaryotic translation initiation factor 4E binding protein. The purpose of this study was to clarify the function of NGDN and its possible mechanism of action in human myeloid leukemia cells. Proliferation inhibition and apoptosis in NGDN over-expressing myeloid multidrug-resistant leukemia cells (K562/A02-NGDN) was significantly higher than in control K562/A02 cells fo...

2012
Ming Liu Xiangzhong Zhao Jin Zhao Lin Xiao Haizhou Liu Cuicui Wang Linyou Cheng Ning Wu Xiukun Lin

Mere15 is a novel polypeptide from Meretrix meretrix Linnaeus with cytotoxicity in solid cancer cells. In this study, we investigated its activity on human K562 chronic myelogenous leukemia cells. Mere15 inhibited the growth of K562 cells with IC₅₀ values of 38.2 μg/mL. Mere15 also caused concentration dependent induction of apoptosis, with overproduction of reactive oxygen species and loss of ...

Journal: :cell journal 0

introduction: in order to determine the multidrug resistance (mdr) phenotype due to p-glycoprotein expression in haematological malignancies including acute myeloblastic leukemia (aml), a well-characterized p-gp expressing cell line was required to validate and standardize flow cytometric assays and to calibrate instruments. therefore, this resistant subline of k562 was established for the firs...

2015
Alessia Finotti Nicoletta Bianchi Enrica Fabbri Monica Borgatti Giulia Breveglieri Jessica Gasparello Roberto Gambari

Rapamycin, an inhibitor of mTOR activity, is a potent inducer of erythroid differentiation and fetal hemoglobin production in β-thalassemic patients. Mithramycin (MTH) was studied to see if this inducer of K562 differentiation also operates through inhibition of mTOR. We can conclude from the study that the mTOR pathway is among the major transcript classes affected by mithramycin-treatment in ...

Journal: :Cancer research 1988
H Hamada E Okochi T Oh-hara T Tsuruo

A low molecular weight cytoplasmic protein (Mr 19,000-22,000) has been reported to be overexpressed in some multidrug-resistant cells. We have found that a cytoplasmic protein with a molecular weight of 22,000 is highly expressed in the human myelogenous leukemia K562 cells resistant to Adriamycin (K562/ADM). The Mr 22,000 protein was shown to be one of the major calcium-binding proteins in the...

Journal: :Nucleic acids research 2000
T H Li C Kim C M Rubin C W Schmid

Alu repeats in K562 cells are unusually hypomethylated and far more actively transcribed than those in other human cell lines and somatic tissues. Also, the level of Alu RNA in K562 cells is relatively insensitive to cell stresses, namely heat shock, adenovirus infection and treatment with cycloheximide, which increase the abundance of Alu RNA in HeLa and 293 cells. Recent advances in understan...

Journal: :iranian journal of blood and cancer 0
mehryar habibi roudkenar mahshid mohammadipour arezou oodi raheleh halabian naser amirizadeh nasser masrouri

background: the rh antigens are expressed as parts of a protein complex in the rbc membrane. this complex is a tetramer, consisting of two molecules of rhag and two molecules of rh proteins. to express rhd in rbc membrane, expression of rhag is essential. this co-expression only occurs in the erythroid lineage. k562 cell line has an erythroid lineage. materials and methods: cord blood was used ...

Journal: :Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2014
Ying Wang Qingshuang Zhang Junxia Zhao Xiaojing Zhao Jinxiu Zhang Li-an Wang

Iso-suillin, an isomer of suillin that belongs to the prenylphenol class of fungal derivatives, was isolated from petroleum ether extracts of Suillus flavus. The IC50 value of iso-suillin in K562 cells was 0.87 μM, which was lower than the positive control cisplatin (19.33 μM). Iso-suillin-treated K562 cells exhibited an increased rate of apoptosis, mitochondrial membrane potential (MMP) depola...

2017
Rui-Fang Fan Ying Lu Zhi-Gang Fang Xiao-Yan Guo Yu-Xin Chen Yi-Chuan Xu Ya-Mei Lei Ke-Fang Liu Dong-Jun Lin Ling-Ling Liu Xiang-Fu Liu

The development of targeted tyrosine kinase inhibitors (TKIs) has succeeded in altering the course of chronic myeloid leukemia (CML). However, a number of patients have failed to respond or experienced disease relapse following TKI treatment. Proviral integration site for moloney murine leukemia virus‑1 (PIM‑1) is a serine/threonine kinase that participates in regulating apoptosis, cell cycle, ...

2017
Angela Ianniciello Pierre-Yves Dumas Claire Drullion Amélie Guitart Arnaud Villacreces Yan Peytour Jean Chevaleyre Philippe Brunet de la Grange Isabelle Vigon Vanessa Desplat Muriel Priault Persio Dello Sbarba Zoran Ivanovic François-Xavier Mahon Jean-Max Pasquet

Albeit tyrosine kinase inhibitors anti-Abl used in Chronic Myeloid Leukemia (CML) block the deregulated activity of the Bcr-Abl tyrosine kinase and induce remission in 90% of patients, they do not eradicate immature hematopoietic compartments of leukemic stem cells. To elucidate if autophagy is important for stem cell survival and/or proliferation, we used culture in low oxygen concentration (0...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید